Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech biotechnology Cancer drug development Drug prices

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Who’s winning in biotech’s tight market? - 3 days ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 12 days ago PharmaVoice 100s: Entrepreneurs - 11 months ago
2	Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto ScienceFreelance Writing	Better Living Through Algae Biotechnology - 4 days ago
3	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Tome Biosciences, once a high-flying gene-editing startup, is floundering - 25 days ago STAT+: Biotech startups post strongest financing numbers in two years - 5 months ago STAT+: As AI proliferates, biopharma companies seek to harness it in clinical trials - 6 months ago STAT+: Biotech incubator Curie.Bio graduates its first startup - 10 months ago STAT+: Life science investors close nearly $6 billion in new funds - 11 months ago
4	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: Tome Biosciences, once a high-flying gene-editing startup, is floundering - 25 days ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - about 1 month ago Is a better CAR-T cell therapy option on the horizon? - 2 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 4 months ago 4 offbeat biotechs making a splash in the life sciences - 5 months ago How a biotech exec is leveraging Big Pharma lessons to advance tRNA - 5 months ago These biotech hotspots are ripe for IPOs - 6 months ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Flagship Pioneering Launches Startup Abiologics to Advance New Class of Biologic Drugs - about 2 months ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Element Biosciences raises another massive round - 2 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 4 months ago How resurrecting extinct species might impact medicine - 6 months ago Lawmakers want to add more Chinese biotechs to defense list - 6 months ago The biotech updates you need to read today - 9 months ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - 9 months ago The biotech news you missed from the weekend - 9 months ago Novartis is building a new radioligand plant in China - 10 months ago Johnson & Johnson bets heavy on AI-driven drug discovery - 10 months ago A new algorithm unveils CRISPR ‘treasure trove’ - 10 months ago These are the need-to-know biotech stories from this weekend - 10 months ago Shrinking Covid vaccine sales has Moderna course-correcting - 11 months ago
8	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	A biotech’s binary bet ends badly - 3 months ago
9	Alex Carchidi Motley Fool Writer, consultant, entrepreneur. Motley Fool. Boston, Massachusetts writingconsultingentrepreneurshipfinance	The Best Biotech Stock to Invest $1,000 in Right Now - 3 months ago
10	Meenakshi Prabhune, PhD The Scientist Editor in chief at The Scientist. Science journalismscicommtravelblogging	Infographic: Synthetic Biology is Transforming Clothes and Cosmetics - 3 months ago Synthetic Biology is in Fashion - 3 months ago Infusion of Artificial Intelligence in Biology - 7 months ago

Journalists covering Biotech